Studying the origins of childhood acute myeloid leukaemia to identify targets for kinder and more effective treatments
Learning more about leukaemia cells in order to design targeted treatments that can increase survivorship and quality of life.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Learning more about leukaemia cells in order to design targeted treatments that can increase survivorship and quality of life.
Investigating how different levels short non-coding RNAs affect germ cell tumour cells, and testing whether medicines altering these levels could be a potential treatment.
Understanding how a protein affects the growth and development of lymphoma cells in order to build the foundations for safer and more effective treatments.
Investigating whether diet or lifestyle changes could help children cope with bone marrow transplants better.
Ependymoma comes back after treatment around half of the time, because some cancer cells are still alive. If doctors could identify these cells and diagnose relapsed ependymoma sooner, children could start treatment earlier.
Looking at whether a pre-existing drug could be an effective and safe treatment due to its ability to target cancer cells directly.
Dr Jess Morgan at Leeds Children’s Hospital and Dr Gemma Bryan at University of Surrey hope to understand more about how hospitals are offering chemotherapy that needs to be given as infusions over a number of days.
Discovering what causes nerve cells to stop working and die years after a Langerhans cell histiocytosis diagnosis.
Looking for repurposed treatments that can fight leukaemia cells in very young children.